Discover how cancer cells survive in low-glucose environments and evade chemotherapy-induced death. New study sheds light on ...

Millions of people around the world are diagnosed with cancer each year. The rapid proliferation of mutated cells can fatally ...

11月5日，南昌大学傅斌教授研究团队在期刊《Cell Death&Disease》上发表了研究论文，题为“USP3 promotes DNA damage response and chemotherapy resistance through ...

Chemotherapy targets cancer cells by disrupting DNA replication and mitotic processes, despite side effects on healthy cells.

A new study has uncovered an unexpected way cancer cells can escape the immune system, making it harder for treatments to work. The study, published in Cancer Cell, explains how a type of cancer cell ...

A new gold-based drug can slow tumour growth in animals by 82% and target cancers more selectively than standard chemotherapy ...

A groundbreaking study by researchers from RMIT University in Australia and Indian institutions has unveiled a novel ...

Joshua K. Sabari, MD, discusses the antitumor activity of second-line lurbinectedin, noting an ORR of 45%, a median DOR of ...

The European Commission has approved mirvetuximab soravtansine for select patients with pretreated folate receptor–alpha (FRα)-positive, platinum-resistant ovarian cancer.

In the fight against antibiotic-resistant pneumonia, new research published in the Antimicrobial Agents and Chemotherapy ...